MaxCyte, Inc. (MXCT)

MaxCyte Revenue

In the year 2023, MaxCyte had annual revenue of $41.29M, a decrease of -6.72%. Revenue in the quarter ending December 31, 2023 was $15.66M with 26.09% year-over-year growth.

• Revenue (ttm): $41.29M
• Revenue Growth: -6.72%
• P/S Ratio: 9.51
• Revenue / Employee: $288,727
• Employees: 143
• Market Cap: 392.57M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	41.29M	-2.97M	-6.72%
Dec 31, 2022	44.26M	10.37M	30.59%
Dec 31, 2021	33.89M	7.73M	29.52%
Dec 31, 2020	26.17M	4.55M	21.04%
Dec 31, 2019	21.62M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.